Carlo E. Neumaier

Enhanced Antitumor Efficacy of Clinical-Grade Vasculature-Targeted Liposomal Doxorubicin

Fabio Pastorino, Daniela Di Paolo, Federica Piccardi et al. · Clinical Cancer Research · 2008 · 101 citations

Pharmacy, Oncology, Pharmacology +17

European organization for research and treatment of cancer (EORTC) 08957 phase II study of topotecan in combination with cisplatin as second-line treatment of refractory and sensitive small cell lung cancer.

Andrea Ardizzoni, C. Manegold, C. Debruyne et al. · PubMed · 2003 · 72 citations · Full text

Medicine, Oncology, Pharmacology +15

Dose-intensive first-line chemotherapy with epirubicin and continuous infusion ifosfamide in adult patients with advanced soft tissue sarcomas: a phase II study

Raffaella Palumbo, Carlo E. Neumaier, Maurizio Cosso et al. · European Journal of Cancer · 1999 · 29 citations

Medicine, Oncology, Pharmacology +13

Gemcitabine, Ifosfamide and Navelbine (GIN): activity and safety of a non-platinum-based triplet in advanced non-small-cell lung cancer (NSCLC)

Editta Baldini, Andrea Ardizzoni, Tiziana Prochilo et al. · British Journal of Cancer · 2001 · 10 citations · Full text

Medicine, Oncology, Pharmacology +14